The history of female Viagra Got approved to fight against "sexism"

On 18 August 2015, the FDA approved the first treatment for "sexual desire
disorder." A pill was appointed Addyi approved for the treatment "acquired,
generalized disorder hypoactive sexual desire disorder (HSDD) in
premenopausal women." Before this drug, there was no treatment approved by
the FDA for women with low libido.
This seems like a good deal, right? Finally, women have their version of
Viagra. It is not in the mood? Let's give him a pill and it will DTF.
Give her a pill and it ll in the mood
Since the early millennia, Big Pharma has invested considerable resources
trying to develop a cure for low female libido. As we know, this is not
just really worry about people welfare, but from a perspective greedy. If
Big Pharma can get addicted women better sex, it will provide a new cash
flow that will last for decades (or more). Also, if you think about it -
have a good sex life can also relieve stress, boredom and decrees to reduce
the divorce rate. Sounds like a win-win.
We can not have a drug without naming a disease. The solution was
to "identify" as a disorder. DSM-IV-TR (Diagnostic and Statistical Manual
of Mental Disorders) named in 2000 "gender dysphoria and gender" as HSDD
(hypoactive sexual desire disorder). This means that premature ejaculation,
paraphilia (fetishism), analloerotic (having no sexual interest in other
people) and lack of sexual desire are in that category.
Now that the "disorder" has been identified, the public was & # 8221
studied; who needs a low sex drive to be tracked and monitored.
 I'm not in the mood. Try another day
Mala? fides
After a few years in the laboratory, it seems that there was a light at the
end of a tunnel. Boehringer Ingelheim, a German pharmaceutical company, was
able to synthesize a new antidepressant called flibanserin. The company
noted that some of the participants reported an increase in their sex
drive. Looks a revised Viagra story. The clinical trial was based on
pre-menopausal women - young women are not yet reproductively useless.
The trial divided the subjects into 2 groups randomly. Each day, each
subject was asked to rate their libido on a 4-point scale (0 - no desire,
intense desire 3). The trial found that there was no particular difference
between the groups.
Moreover, it seems that, taking flibanserin, there were side effects:
dizziness, drowsiness, and nausea. Based on these, the FDA rejected the new
drug based on the benefits of risk and failure to demonstrate a statistical
effect on sexual desire and entry criteria too restrictive for the two
Phase 3 trials . the message was received and Boehringer Ingelheim has
decided not to throw money at a time.
Throwing money after bad money is not a calculated step
Human garbage is gold with another man. A new pharmaceutical company called
Sprout Pharmaceuticals think they can win the gold. In fact, the looks of
it, the founders thought exactly that. They approached and Boehringer
Ingelheim bought the rights to flibanserin, after raising $ 20M. Sprout was
led by Cindy and Robert Whitehead who both had extensive experience in the
pharmaceutical industry.
Cindy and Robert Whitehead
They looked comments from the FDA decided to change tactics. Instead of a
daily report, it has become a ratio of 4 weeks (which means that the
subjects reported every week over the last four weeks). It smelled bad - we
all know that the longer you wait with subjective feelings reports (and
desire is totally subjective), more prone to error is. The company
resubmitted the drug to the FDA in 2013. The FDA rejected again based on
the same risk / benefit ratio.
What do you do when the government refuses to give you a license to print
money? You lobby and use the classic straw man - feminism. The advocacy
group created company called even the score D.C. and began using feminist
language to shame the establishment and call the FDA "macho". They went
after and MPs have to write letters to the FDA. They went to a campaign.
Here one of the ads:

The pressure worked, but it was noticed even by BuzzFeed, which we all know
is not a harsh critique of liberal / feminist policies. In 2015, the FDA
approved the drug for commercial use, even if nothing changed
fundamentally. You can read the pressure in the output:
The FDA has recognized for some time the challenges involved in the
development of treatments for female sexual dysfunction.
Since feminists love to beat the drum on equality, it is important to note
that there is no treatment for men:
Before approving Addyi, there was no treatment approved by the FDA for
disorders of sexual desire in men or women.
Downhill and fast
Immediately after the approval, Sprout Pharmaceuticals was acquired by
Valeant Pharmaceuticals for the modest sum of $ 1 billion. Valeant think,
but they had a lot going for them. However, as stated Murphy's
Law: "Whatever can go wrong will go wrong. "- as the" female Viagra ".
Valeant had a practice of buying drugs and then driving them up prices. It
was all good, until the government has noticed. It was in October 2015.
Worse, Valeant has doubled the price of Addyi to $ 800. Addyi also faces
the problem of distribution, Valeant has chosen a company called Philidor,
which went bankrupt shortly.
Yes. He was also quick
Sprout shareholders angered by Valeant practice, have contacted the
management of Valeant and demanded explanations. The height of it was
deposited in November last complaint is always set in court. Sales in 2016
were poor - about $ 10 million worldwide. Viagra comparison is not
flattering - it sold $ 788m in its first year on the market. Valeant is now
bleeding money, and its largest shareholder sold in March this year at a
reported loss of $ 2.8 billion.
Conclusion
Yes. I'm a billion dollars and all I had to do is to manipulate the
government
This is a story of greed and abuse of power. It shows how the state can be
easily handled using tactics of "macho" of humiliation. Furthermore, the
only people to come on top Sprout Pharmaceuticals shareholders are led by
founders who had completed and just changed their pockets. It was almost
a "hit and force" business plan. Everyone connected to the "pink Viagra"
paid a heavy price. It was also a clear case where feminism was nothing
more than a vessel for a lot of money. Who cares about health, when big
money is on the line?
From the point of view red pill, we know that a woman's sexual desire is a
fluid and fickle phenomenon. Everything can not be repaired by drugs and
chemicals. Life is more than measurable quantities. In any case, we all
expect to see if and when a "female Viagra" real will on the market - how
many women actually use. Women thwart nature hypergamious not communicate
that to have a satisfying sexual relationship with a beta.
Read more: The anti-feminism wisdom of the Bible